News
ALURD
0.627
+10.99%
0.062
Allurion Technologies Executes Reverse Stock Split to Regain Listing
TipRanks · 15h ago
Allurion enacts 1-for-15 reverse stock split for exchange relisting
Seeking Alpha · 16h ago
Allurion Technologies Announces 1-For-15 Reverse Stock Split To Support NYSE Re-Listing Efforts
Benzinga · 17h ago
Allurion to execute 1-for-15 reverse stock split June 18
PUBT · 17h ago
Allurion advances NYSE re-listing plan with 1-for-15 reverse stock split
PUBT · 17h ago
Allurion Advances Plan to Re-List
Barchart · 22h ago
Weekly Report: what happened at ALUR last week (0608-0612)?
Weekly Report · 3d ago
Weekly Report: what happened at ALUR last week (0601-0605)?
Weekly Report · 06/08 10:17
Allurion announces ‘successful early traction’ in US. Allurion Program launch
TipRanks · 06/02 14:53
Allurion says early US launch patients lose 8%-11% body weight in first four weeks
PUBT · 06/02 13:03
Weekly Report: what happened at ALUR last week (0525-0529)?
Weekly Report · 06/01 10:21
Allurion dismisses Deloitte, names CBIZ as new auditor
PUBT · 05/27 20:36
Weekly Report: what happened at ALUR last week (0518-0522)?
Weekly Report · 05/25 10:25
Weekly Report: what happened at ALUR last week (0511-0515)?
Weekly Report · 05/18 10:25
Saudi Public Investment Fund Sells Entire Stake in Allurion Technologies, Exits Position of 1,148,436 Shares
Benzinga · 05/15 15:03
Weekly Report: what happened at ALUR last week (0504-0508)?
Weekly Report · 05/11 10:22
Weekly Report: what happened at ALUR last week (0427-0501)?
Weekly Report · 05/04 10:19
Weekly Report: what happened at ALUR last week (0420-0424)?
Weekly Report · 04/27 10:22
Allurion Technologies treats first commercial patients in the U.S.
TipRanks · 04/20 14:32
Weekly Report: what happened at ALUR last week (0413-0417)?
Weekly Report · 04/20 10:18
More
Webull provides a variety of real-time ALURD stock news. You can receive the latest news about ALLURION TECHNOLOGIES INC through multiple platforms. This information may help you make smarter investment decisions.
About ALURD
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.